NCT06027320Completed
The Retain Your Brain Health Study (RetainYourBrain.com)
Risk Education Technology As Individualized Neuroprotection
Source: ClinicalTrials.gov · Last updated 1 Nov 2024
Brief summary (registry, in English)
The goal of this clinical trial is to test a cell phone-based online program that provides Alzheimer's risk assessments and memory tests over a 6-month period. The main question it aims to answer is whether online software can help reduce the risk of Alzheimer's disease (AD) through digital education and tracking. Participants will visit RetainYourBrain.com to answer questions about their risk factors for AD and take online word recall and card game cognitive tests. Researchers will track progress over time and compare different strategies of Alzheimer's education to see if it is possible to protect brain health, reduce Alzheimer's risk, and improve memory function.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 992 (actual)
- First submitted
- 25 Aug 2023
- Start date
- 7 Dec 2023
- Primary completion date
- 16 Sept 2024
- Lead sponsor
- Retain Health, Inc
- Diseases
- Alzheimer disease
- NCT number
- NCT06027320
What you commit to
- Study type: Interventional
- Participants enrolled: 992
- From 7 Dec 2023 to the primary completion date, 16 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- have a diagnosis of dementia due to AD
- other dementia
- current treatment for cancer
- diagnosis of Parkinson's disease, amyotrophic lateral sclerosis, Lewy body dementia, frontotemporal disorders, multiple sclerosis, or other neurodegenerative disease
- current treatment for an eating disorder
- currently prescribed insulin for type I or II diabetes
Other
- women who are currently pregnant or who plan on becoming pregnant in the next 6 months
- BMI \<18.5 kg/m2
- consuming \>35 alcoholic drinks/week for men or \>28 alcoholic drinks/week for women
- severe depression (PHQ-9 score of more than 15)
- inability to give informed consent or complete identity verification
- participating in another AD trial.
Who the study is looking for
- be at least 53 years of age
- have a family history of Alzheimer's Disease (AD)
- have a compatible phone/device (phone allowing text messages and with internet access, and/or tablet device with the same capabilities)
- a minimum of one of the following risk factors: body mass index (BMI) of \< 25 kg/m2, history of pre-diabetes/diabetes, high blood pressure, high cholesterol, smoking, low physical activity, low fish intake (\< 3 times per month), high alcohol intake (\< 7 servings per week for a women and \<14 servings a week for men), diagnosed with mild or moderate depression.
Age in the registry: 53 years to 105 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Retain Health, Inc. Coordinator of this site? Confirm its status | Bedford | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.